{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:43:24Z","timestamp":1790153004414,"version":"4.0.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>To compare symptoms of clinical androgen deficiency between men with migraine, men with cluster headache and non-headache male controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed a cross-sectional study using two validated questionnaires to assess symptoms of androgen deficiency in males with migraine, cluster headache, and non-headache controls. Primary outcome was the mean difference in androgen deficiency scores. Generalized linear models were used adjusting for age, BMI, smoking and lifetime depression. As secondary outcome we assessed the percentage of patients reporting to score below average on four sexual symptoms (beard growth, morning erections, libido and sexual potency) as these items were previously shown to more specifically differentiate androgen deficiency symptoms from (comorbid) anxiety and depression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The questionnaires were completed by <jats:italic>n<\/jats:italic>\u2009=\u2009534\/853 (63%) men with migraine, <jats:italic>n<\/jats:italic>\u2009=\u2009437\/694 (63%) men with cluster headache and <jats:italic>n<\/jats:italic>\u2009=\u2009152\/209 (73%) controls. Responders were older compared to non-responders and less likely to suffer from lifetime depression.<\/jats:p>\n                <jats:p>Patients reported more severe symptoms of clinical androgen deficiency compared with controls, with higher AMS scores (Aging Males Symptoms; mean difference\u2009\u00b1\u2009SE: migraine 5.44\u2009\u00b1\u20090.90, <jats:italic>p<\/jats:italic>\u2009&lt;\u2009\u00a00.001; cluster headache 5.62\u2009\u00b1 0.99, <jats:italic>p\u2009&lt;<\/jats:italic>\u2009\u00a00.001) and lower qADAM scores (quantitative Androgen Deficiency in the Aging Male; migraine: \u2212\u20093.16\u2009\u00b1\u20090.50, <jats:italic>p\u2009&lt;<\/jats:italic>\u2009\u00a00.001; cluster headache: \u2212\u20095.25\u2009\u00b1\u20090.56, <jats:italic>p\u2009&lt;<\/jats:italic>\u2009\u00a00.001). Additionally, both patient groups more often reported to suffer from any of the specific sexual symptoms compared to controls (18.4% migraine, 20.6% cluster headache, 7.2% controls, <jats:italic>p<\/jats:italic>\u2009=\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Men with migraine and cluster headache more often suffer from symptoms consistent with clinical androgen deficiency than males without a primary headache disorder.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s10194-021-01334-3","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T10:12:28Z","timestamp":1634638348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical symptoms of androgen deficiency in men with migraine or cluster headache: a cross-sectional cohort study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9509-7233","authenticated-orcid":false,"given":"Iris E.","family":"Verhagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roemer B.","family":"Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlijn M. A.","family":"Kruitbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"MaassenVanDenBrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Fronczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisela M.","family":"Terwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"1334_CR1","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1212\/WNL.53.3.537","volume":"53","author":"LJ Launer","year":"1999","unstructured":"Launer LJ, Terwindt GM, Ferrari MD (1999) The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53:537\u2013542","journal-title":"Neurology"},{"key":"1334_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10194-011-0329-1","volume":"12","author":"EV Kvisvik","year":"2011","unstructured":"Kvisvik EV, Stovner LJ, Helde G, Bovim G, Linde M (2011) Headache and migraine during pregnancy and puerperium: the MIGRA-study. J Headache Pain 12:443\u2013451","journal-title":"J Headache Pain"},{"key":"1334_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/0378-5122(93)90121-W","volume":"17","author":"I Neri","year":"1993","unstructured":"Neri I, Granella F, Nappi R, Manzoni GC, Facchinetti F, Genazzani AR (1993) Characteristics of headache at menopause: a clinico-epidemiologic study. Maturitas 17:31\u201337","journal-title":"Maturitas"},{"key":"1334_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11916-011-0200-8","volume":"15","author":"RE Nappi","year":"2011","unstructured":"Nappi RE, Albani F, Sances G, Terreno E, Brambilla E, Polatti F (2011) Headaches during pregnancy. Curr Pain Headache Rep 15:289\u2013294","journal-title":"Curr Pain Headache Rep"},{"key":"1334_CR5","doi-asserted-by":"publisher","first-page":"e374","DOI":"10.1212\/WNL.0000000000005855","volume":"91","author":"WPJ van Oosterhout","year":"2018","unstructured":"van Oosterhout WPJ, Schoonman GG, van Zwet EW et al (2018) Female sex hormones in men with migraine. Neurology 91:e374\u2013e381","journal-title":"Neurology"},{"key":"1334_CR6","doi-asserted-by":"publisher","unstructured":"Frederiksen HH, Lund NL, Barloese MC, Petersen AS, Jensen RH. Diagnostic delay of cluster headache: A cohort study from the Danish Cluster Headache Survey. Cephalalgia. 2020;40(1):49-56. https:\/\/doi.org\/10.1177\/0333102419863030. Epub 2019 Jul 10.","DOI":"10.1177\/0333102419863030"},{"key":"1334_CR7","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1468-2982.1991.1104169.x","volume":"11","author":"GC Manzoni","year":"1991","unstructured":"Manzoni GC, Micieli G, Granella F, Tassorelli C, Zanferrari C, Cavallini A (1991) Cluster headache course over ten years in 189 patients. Cephalalgia 11:169\u2013174","journal-title":"Cephalalgia"},{"key":"1334_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/0333102417739584","volume":"39","author":"A Labastida-Ram\u00edrez","year":"2019","unstructured":"Labastida-Ram\u00edrez A, Rubio-Beltr\u00e1n E, Villal\u00f3n CM, MaassenVanDenBrink A (2019) Gender aspects of CGRP in migraine. Cephalalgia 39:435\u2013444","journal-title":"Cephalalgia"},{"key":"1334_CR9","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1177\/0333102411418846","volume":"31","author":"WP van Oosterhout","year":"2011","unstructured":"van Oosterhout WP, Weller CM, Stam AH et al (2011) Validation of the web-based LUMINA questionnaire for recruiting large cohorts of migraineurs. Cephalalgia 31:1359\u20131367","journal-title":"Cephalalgia"},{"key":"1334_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1177\/0333102413479835","volume":"33","author":"LA Wilbrink","year":"2013","unstructured":"Wilbrink LA, Weller CM, Cheung C et al (2013) Stepwise web-based questionnaires for diagnosing cluster headache: LUCA and QATCH. Cephalalgia 33:924\u2013931","journal-title":"Cephalalgia"},{"key":"1334_CR11","first-page":"1","volume":"38","author":"Headache Classification Committee of the International Headache Society","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (2018) The international classification of headache disorders, 3rd edition. Cephalalgia 38:1\u2013211","journal-title":"Cephalalgia"},{"key":"1334_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1177\/0333102415607856","volume":"36","author":"I De Coo","year":"2016","unstructured":"De Coo I, Wilbrink L, Haan J, Ferrari M, Terwindt G (2016) Evaluation of the new ICHD-3 beta cluster headache criteria. Cephalalgia 36:547\u2013551","journal-title":"Cephalalgia"},{"key":"1334_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF03345527","volume":"28","author":"LA Heinemann","year":"2005","unstructured":"Heinemann LA (2005) Aging Males' symptoms scale: a standardized instrument for the practice. J Endocrinol Investig 28:34\u201338","journal-title":"J Endocrinol Investig"},{"key":"1334_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1477-7525-1-77","volume":"1","author":"I Daig","year":"2003","unstructured":"Daig I, Heinemann LA, Kim S et al (2003) The aging Males' symptoms (AMS) scale: review of its methodological characteristics. Health Qual Life Outcomes 1:77","journal-title":"Health Qual Life Outcomes"},{"key":"1334_CR15","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/ijir.2009.35","volume":"22","author":"O Mohamed","year":"2010","unstructured":"Mohamed O, Freundlich RE, Dakik HK et al (2010) The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. Int J Impot Res 22:20\u201324","journal-title":"Int J Impot Res"},{"key":"1334_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1080\/13685530412331284650","volume":"7","author":"CW Kratzik","year":"2004","unstructured":"Kratzik CW, Reiter WJ, Riedl AM et al (2004) Hormone profiles, body mass index and aging male symptoms: results of the Androx Vienna municipality study. Aging Male 7:188\u2013196","journal-title":"Aging Male"},{"key":"1334_CR17","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1210\/jc.2007-1972","volume":"93","author":"FC Wu","year":"2008","unstructured":"Wu FC, Tajar A, Pye SR et al (2008) Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European male aging study. J Clin Endocrinol Metab 93:2737\u20132745","journal-title":"J Clin Endocrinol Metab"},{"key":"1334_CR18","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1212\/WNL.0000000000003376","volume":"87","author":"MA Louter","year":"2016","unstructured":"Louter MA, Pelzer N, de Boer I et al (2016) Prevalence of lifetime depression in a large hemiplegic migraine cohort. Neurology 87:2370\u20132374","journal-title":"Neurology"},{"key":"1334_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/13685538.2013.807428","volume":"16","author":"CP Lee","year":"2013","unstructured":"Lee CP, Jiang JR, Chen Y et al (2013) The \u201caging Males\u2019 symptoms\u201d (AMS) scale assesses depression and anxiety. Aging Male 16:97\u2013101","journal-title":"Aging Male"},{"key":"1334_CR20","doi-asserted-by":"crossref","unstructured":"Classification Committee of the International Headache Society (2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1\u2013211","DOI":"10.1177\/0333102417738202"},{"key":"1334_CR21","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1530\/EJE-20-1375","volume":"184","author":"RHH Groenwold","year":"2021","unstructured":"Groenwold RHH, Goeman JJ, Cessie SL, Dekkers OM (2021) Multiple testing: when is many too much? Eur J Endocrinol 184:E11\u2013e14","journal-title":"Eur J Endocrinol"},{"key":"1334_CR22","doi-asserted-by":"publisher","first-page":"8079","DOI":"10.4081\/ni.2019.8079","volume":"11","author":"LBE Shields","year":"2019","unstructured":"Shields LBE, Seifert T, Shelton BJ, Plato BM (2019) Testosterone levels in men with chronic migraine. Neurol Int 11:8079","journal-title":"Neurol Int"},{"key":"1334_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1468-2982.1986.0601029.x","volume":"6","author":"F Facchinetti","year":"1986","unstructured":"Facchinetti F, Nappi G, Cicoli C et al (1986) Reduced testosterone levels in cluster headache: a stress-related phenomenon? Cephalalgia 6:29\u201334","journal-title":"Cephalalgia"},{"key":"1334_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1468-2982.1983.0301041.x","volume":"3","author":"A Romiti","year":"1983","unstructured":"Romiti A, Martelletti P, Gallo MF, Giacovazzo M (1983) Low plasma testosterone levels in cluster headache*. Cephalalgia 3:41\u201344","journal-title":"Cephalalgia"},{"key":"1334_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/j.1526-4610.1982.hed2204162.x","volume":"22","author":"A Klimek","year":"1982","unstructured":"Klimek A (1982) Plasma testosterone levels in patients with cluster. Headache. 22:162\u2013164","journal-title":"Headache."},{"key":"1334_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1526-4610.1978.hed1805265.x","volume":"18","author":"RF Nelson","year":"1978","unstructured":"Nelson RF (1978) Testosterone levels in cluster and non-cluster Migrainous headache patients. Headache 18:265\u2013267","journal-title":"Headache"},{"key":"1334_CR27","doi-asserted-by":"publisher","unstructured":"Murialdo G, Fanciullacci M, Nicolodi M, Filippi U, De Palma D, Sicuteri F, Polleri A. Cluster headache in the male: sex steroid pattern and gonadotropic response to luteinizing hormone releasing hormone. Cephalalgia. 1989;9(2):91-8. https:\/\/doi.org\/10.1046\/j.1468-2982.1989.0902091.x.","DOI":"10.1046\/j.1468-2982.1989.0902091.x"},{"key":"1334_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1212\/01.WNL.0000130338.62037.CC","volume":"63","author":"T Pringsheim","year":"2004","unstructured":"Pringsheim T, Gooren L (2004) Migraine prevalence in male to female transsexuals on hormone therapy. Neurology 63:593\u2013594","journal-title":"Neurology"},{"key":"1334_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.maturitas.2012.01.006","volume":"71","author":"R Glaser","year":"2012","unstructured":"Glaser R, Dimitrakakis C, Trimble N, Martin V (2012) Testosterone pellet implants and migraine headaches: a pilot study. Maturitas 71:385\u2013388","journal-title":"Maturitas"},{"key":"1334_CR30","first-page":"419","volume":"36","author":"EM Lichten","year":"1991","unstructured":"Lichten EM, Bennett RS, Whitty AJ, Daoud Y (1991) Efficacy of danazol in the control of hormonal migraine. J Reprod Med 36:419\u2013424","journal-title":"J Reprod Med"},{"key":"1334_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1526-4610.2006.00436.x","volume":"46","author":"MJ Stillman","year":"2006","unstructured":"Stillman MJ (2006) Testosterone replacement therapy for treatment refractory cluster headache. Headache 46:925\u2013933","journal-title":"Headache"},{"key":"1334_CR32","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1023\/A:1015238102830","volume":"13","author":"NE Allen","year":"2002","unstructured":"Allen NE, Appleby PN, Davey GK, Key TJ (2002) Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control 13:353\u2013363","journal-title":"Cancer Causes Control"},{"key":"1334_CR33","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1042\/CS20010011","volume":"100","author":"KM English","year":"2001","unstructured":"English KM, Pugh PJ, Parry H, Scutt NE, Channer KS, Jones TH (2001) Effect of cigarette smoking on levels of bioavailable testosterone in healthy men. Clin Sci (Lond) 100:661\u2013665","journal-title":"Clin Sci (Lond)"},{"key":"1334_CR34","first-page":"1041","volume":"11","author":"SM Gapstur","year":"2002","unstructured":"Gapstur SM, Gann PH, Kopp P, Colangelo L, Longcope C, Liu K (2002) Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomark Prev 11:1041\u20131047","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1334_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb05631.x","volume":"928","author":"D Harman","year":"2001","unstructured":"Harman D (2001) Aging: overview. Ann N Y Acad Sci 928:1\u201321","journal-title":"Ann N Y Acad Sci"},{"key":"1334_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.14310\/horm.2002.1445","volume":"12","author":"W Wang","year":"2013","unstructured":"Wang W, Yang X, Liang J et al (2013) Cigarette smoking has a positive and independent effect on testosterone levels. Hormones (Athens) 12:567\u2013577","journal-title":"Hormones (Athens)"},{"key":"1334_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/oby.20256","volume":"21","author":"RP Wildman","year":"2013","unstructured":"Wildman RP, Wang D, Fernandez I et al (2013) Associations of testosterone and sex hormone binding globulin with adipose tissue hormones in midlife women. Obesity (Silver Spring) 21:629\u2013636","journal-title":"Obesity (Silver Spring)"},{"key":"1334_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s10194-020-01120-7","volume":"21","author":"BS Kim","year":"2020","unstructured":"Kim BS, Chung PW, Kim BK et al (2020) The impact of remission and coexisting migraine on anxiety and depression in cluster headache. J Headache Pain 21:58","journal-title":"J Headache Pain"},{"key":"1334_CR39","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1212\/WNL.0000000000003282","volume":"87","author":"MA Louter","year":"2016","unstructured":"Louter MA, Wilbrink LA, Haan J et al (2016) Cluster headache and depression. Neurology 87:1899\u20131906","journal-title":"Neurology"},{"key":"1334_CR40","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1526-4610.2011.02024.x","volume":"52","author":"MS Robbins","year":"2012","unstructured":"Robbins MS, Bronheim R, Lipton RB et al (2012) Depression and anxiety in episodic and chronic cluster headache: a pilot study. Headache 52:600\u2013611","journal-title":"Headache"},{"key":"1334_CR41","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12529-016-9620-5","volume":"24","author":"LN Dindo","year":"2017","unstructured":"Dindo LN, Recober A, Haddad R, Calarge CA (2017) Comorbidity of migraine, major depressive disorder, and generalized anxiety disorder in adolescents and young adults. Int J Behav Med 24:528\u2013534","journal-title":"Int J Behav Med"},{"key":"1334_CR42","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1177\/0333102413483930","volume":"33","author":"PM Rist","year":"2013","unstructured":"Rist PM, Schurks M, Buring JE, Kurth T (2013) Migraine, headache, and the risk of depression: prospective cohort study. Cephalalgia 33:1017\u20131025","journal-title":"Cephalalgia"}],"updated-by":[{"DOI":"10.1186\/s10194-021-01346-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000}}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-021-01334-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-021-01334-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T12:03:15Z","timestamp":1636459395000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-021-01334-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1334"],"URL":"https:\/\/doi.org\/10.1186\/s10194-021-01334-3","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s10194-021-01346-z","asserted-by":"object"}]},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s10194-021-01346-z","URL":"https:\/\/doi.org\/10.1186\/s10194-021-01346-z","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the medical ethics committee of Leiden University Medical Center. All subjects provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"I.E. Verhagen has received research grants from ZonMw and the Dutch Brain Foundation. R.B. Brandt has received support for conference visits from Allergan. C.M.A. Kruitbosch reports no disclosures. A. MaassenVanDenBrink reports consultancy or industry support from Novartis, Lilly and Teva, and independent support from the Dutch Research Council (VICI grant 09150181910040), The Netherlands Organisation for Health Research and Development (ZonMw) and the Dutch Heart & Brain Foundations. R. Fronczek has received consultancy support from Novartis, Lilly, Teva, Allergan, and independent support from the Dutch Brain Foundation and Innovation Fund Dutch Healthcare Providers. G.M. Terwindt reports consultancy support from Novartis, Allergan, Lilly, and Teva, and independent support from Dutch Organization for Scientific Research, the Dutch Heart & Brain Foundations, IRRF and Dioraphte.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}